ApprovalTrail

Approval · Notice of Compliance 35502 · 2025

SPRYCEL: Notice of Compliance 35502

Issued June 11, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
35502
Date
June 11, 2025
Company
Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Update to the Product Monograph as per advisement letter

Products in this notice

BrandDINStatus today
SPRYCELNot yet assigned—

Medicinal ingredients